Trial Profile
A Randomized Multicenter Phase 2 Study of PLX3397 Plus Decitabine Versus Decitabine Alone in Subjects with Newly Diagnosed FLT3-ITD-positive Acute Myeloid Leukemia Who Are 60 Years of Age or Older and Who Are Not Candidates for Intensive Chemotherapy
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 29 Jan 2015
Price :
$35
*
At a glance
- Drugs Pexidartinib (Primary) ; Decitabine
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 29 Jan 2015 New trial record